AGI.do

Products

What will AGI do for Aditoprim?

This classification denotes a dihydrofolate reductase inhibitor and anti-infective agent with the molecular formula C15H21N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z81WDX2ZH, chemically known as 2,4-pyrimidinediamine, 5-((4-(dimethylamino)-3,5-dimethoxyphenyl)methyl)- but more generally known as aditoprim, which bears US NIH Compound Identifier 68755. European Medicines Agency schedules Aditoprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05275MIG. The term ADITOPRIM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 37, No. 6, 1983, List 23). ADITOPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1C(N(C)C)C(OC)CC(CC2C(NC(NC2)N)N)C1)C.

How AGI delivers it

Four ways AGI delivers for Aditoprim

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aditoprim, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aditoprim, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aditoprim connects

measured by

  • Assay Puritymodel
  • Particle Size Distributionmodel
  • Residual Solvent Contentmodel

Go deeper

Explore Aditoprim

Read the deeper take on agi.asView as markdown